#USA #Fort Lauderdale #Stomach Cancer #AACR #Debbie's Dream

Funding New Frontiers in Gastric Cancer Research

The Debbie's Dream Foundation (DDF), which focuses on curing stomach cancer, has announced a significant new collaboration with the American Association for Cancer Research (AACR). This partnership aims to foster innovative research projects that will transform the landscape of gastric cancer treatment and care.

The Grant Initiative

On June 11, 2026, the two organizations revealed the AACR-Debbie's Dream Foundation Innovation and Discovery Grant, a funding initiative designed specifically to stimulate pioneering ideas in gastric cancer research. This funding opportunity offers a total of $100,000 over a two-year period—$50,000 each year for two years—to support groundbreaking research aimed at improving detection, treatment, and overall outcomes for patients diagnosed with gastric cancer.

The parameters for this grant allow applications not only from established researchers in the field of gastric cancer but also encourage applications from scientists working in other areas of cancer research whose expertise may contribute to innovative approaches for improving care for stomach cancer patients. This initiative is expected to attract the attention of talented researchers eager to make a difference in this underfunded area of cancer treatment.

Research Impact

The funds allocated through this grant can be used for various crucial aspects of research, including:

• - Laboratory supplies and essential equipment.
• - Expenses related to research activities.
• - Supplemental salary support for researchers involved in creative and exploratory studies.

Moreover, the grant recipient will be part of the AACR’s Annual Grantee Recognition Event and the Annual Grantee Summit. These events present unique opportunities for networking with fellow researchers in the cancer community. Here, recipients can engage deeply in discussions, collaborate, and contribute to ongoing advancements in cancer research. This collaborative environment is a crucial aspect as it fosters a spirit of innovation and motivates researchers to exchange ideas, thereby, catalyzing further developments in gastric cancer treatment.

Amanda Pullinger, the CEO of Debbie's Dream Foundation, expressed the organization’s commitment towards enhancing research capabilities: "Research gives hope to patients and families facing stomach cancer. In collaboration with AACR, we are proud to support innovative research that can lead to earlier detection, better treatments, and improved outcomes for future generations."

Since 2014, DDF and AACR have jointly played a pivotal role in advancing the understanding of gastric cancer and supporting researchers dedicated to improving patient outcomes. The collaborative work has already seen a positive impact, with DDF contributing around $1.65 million towards research efforts that nurture early-career investigators and award coveted AACR Scholar-in-Training Awards. When combined with DDF’s individual investments in notable institutions like Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center, the total commitment towards gastric cancer research exceeds $2.5 million since DDF’s inception.

By supporting more than 20 researchers and trainees, DDF and AACR are not just making strides in research; they are laying down a solid foundation for future generations of scientists committed to enhancing gastric cancer treatment.

Application Process

Eligible applicants for this grant must possess a doctoral degree (PhD, MD, MD/PhD, or equivalent) and be independent investigators associated with an academic, medical, or nonprofit research framework. Applications that address any area of gastric cancer research will be entertained.

The deadline to submit applications for the AACR-Debbie's Dream Foundation Innovation and Discovery Grant is July 22, 2026. Interested parties may find more details on the official AACR website.

The DDF continues to build upon the legacy of its founder, Debbie Zelman, who catalyzed a movement to raise awareness about gastric cancer. Since her own diagnosis with stage IV gastric cancer in 2008, she has since become a significant advocate for increased funding and research in this field. Even after her passing in December 2017, her vision lives on through DDF’s ongoing charitable work, striving tirelessly to fulfill the dream of curing stomach cancer. By investing in upcoming research projects, DDF remains committed to advancing the care and support available for those grappling with gastric cancer.

To learn more about DDF and their initiatives, visit their website at www.DebbiesDream.org.